lapatinib has been researched along with Animal Mammary Carcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benonisson, H; Breukel, C; Brouwers, C; Camps, M; Claassens, J; Fransen, MF; Linssen, MM; Ossendorp, F; Sow, HS; van Hall, T; Verbeek, JS | 1 |
| Choi, J; Dann, P; Friedman, PA; Gefter, JV; Jeong, J; Kim, W; Takyar, F; Wysolmerski, JJ | 1 |
| Cecil, DL; Disis, ML; Gad, E; Herendeen, DR; Lai, VP; Lubet, RA; O'Meara, MM; Park, KH; Treuting, PM | 1 |
| Abt, MA; Hill, EG; Yeh, ES | 1 |
| Bode, AM; Carper, A; Cho, YY; Ericson, ME; Grubbs, CJ; Langfald, A; Li, J; Lubet, RA | 1 |
| Deng, X; Erfani, SF; Hemler, ME; Hoff, J; Jin, H; Kaetzel, DM; Li, Q; Novak, M; Rabinovitz, I; Sharma, C; Sonnenberg, A; Stipp, CS; Yang, H; Yang, XH; Yi, Y; Zhou, P | 1 |
6 other study(ies) available for lapatinib and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Immunogenicity of rat-neu
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Flow Cytometry; Lapatinib; Leukocyte Common Antigens; Male; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Quinolines; Rats; Receptor, ErbB-2; Signal Transduction; T-Lymphocytes; Trastuzumab | 2020 |
Inhibition of ezrin causes PKCĪ±-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cytoskeletal Proteins; Female; Humans; Lapatinib; Mammary Neoplasms, Animal; Protein Kinase C-alpha; Receptor, ErbB-2; Signal Transduction | 2019 |
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.
Topics: Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Female; Insulin-Like Growth Factor Binding Protein 2; Lapatinib; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Neoplasm Invasiveness; Precancerous Conditions; Quinazolines; Receptor, ErbB-2; Receptor, IGF Type 1; T-Lymphocytes; Tetrahydronaphthalenes; Tumor Cells, Cultured; Vaccines, Subunit | 2013 |
Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
Topics: Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Autophagy; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mammary Neoplasms, Animal; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2015 |
Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Female; Humans; Lapatinib; Mammary Neoplasms, Animal; Models, Chemical; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Signal Transduction | 2011 |
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
Topics: Animals; Butadienes; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Female; Focal Adhesion Kinase 1; Humans; Integrin alpha6beta4; Lapatinib; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Metastasis; Nitriles; Phosphorylation; Quinazolines; Receptor, ErbB-2; Tetraspanin 24; Transendothelial and Transepithelial Migration | 2012 |